Impact of Educational Interventions on Psychological Distress During Allogeneic Hematopoietic Stem Cell Transplantation: A Randomised Study.

Allogeneic hematopoietic stem cell transplantation Patient engagement Psychological support Quality of life Therapeutic patient education

Journal

Mediterranean journal of hematology and infectious diseases
ISSN: 2035-3006
Titre abrégé: Mediterr J Hematol Infect Dis
Pays: Italy
ID NLM: 101530512

Informations de publication

Date de publication:
2020
Historique:
received: 19 06 2020
accepted: 16 08 2020
entrez: 21 9 2020
pubmed: 22 9 2020
medline: 22 9 2020
Statut: epublish

Résumé

Physical and psychological factors, like wrong attitudes and behaviours, can negatively influence the health outcomes of the patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT). Educational interventions aiming to improve knowledge on side effects, risks, complications and preventive behaviour can reduce psychological distress, and improve quality of life (QoL). We aimed to compare a standard approach with therapeutic patient education (TPE) to analyse the impact on AHSCT patients' QoL, psychological distress and knowledge of AHSCT side effects, risks complications and preventive behaviour. A prospective interventional study was conducted analysing data of 36 patients who received one of two different educational approaches, which were a standard approach (not-exposed) or TPE (exposed). In the exposed group QoL improved 14 days after transplantation (42.2 vs 25.6; p<0.03) and at time of discharge (36.6 vs 54.4; p<0.005). Anxiety and depression were better controlled in the exposed group, both at hospitalisation and discharge (anxiety: 48.1 vs 53.2; 46.4 vs 51.6. p<0.04; depression: 49 vs 55.3; 48 vs 54.3, p<0.03). Knowledge of AHSCT risks and complications improved in exposed patients, both at admission (10.1/15 vs 8/15 correct answers; p<0.01) and discharge (10.7/15 vs 8.8/15 correct answer; p<0.03). The TPE for AHSCT patients improved knowledge, reduced anxiety and depression, which consequently increasing QoL. Therefore, we recommend our approach to further engage patients in the treatment plan, which should specifically take place prior to AHSCT initiation.

Sections du résumé

BACKGROUND BACKGROUND
Physical and psychological factors, like wrong attitudes and behaviours, can negatively influence the health outcomes of the patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT). Educational interventions aiming to improve knowledge on side effects, risks, complications and preventive behaviour can reduce psychological distress, and improve quality of life (QoL). We aimed to compare a standard approach with therapeutic patient education (TPE) to analyse the impact on AHSCT patients' QoL, psychological distress and knowledge of AHSCT side effects, risks complications and preventive behaviour.
MATERIAL AND METHODS METHODS
A prospective interventional study was conducted analysing data of 36 patients who received one of two different educational approaches, which were a standard approach (not-exposed) or TPE (exposed).
RESULTS RESULTS
In the exposed group QoL improved 14 days after transplantation (42.2 vs 25.6; p<0.03) and at time of discharge (36.6 vs 54.4; p<0.005). Anxiety and depression were better controlled in the exposed group, both at hospitalisation and discharge (anxiety: 48.1 vs 53.2; 46.4 vs 51.6. p<0.04; depression: 49 vs 55.3; 48 vs 54.3, p<0.03). Knowledge of AHSCT risks and complications improved in exposed patients, both at admission (10.1/15 vs 8/15 correct answers; p<0.01) and discharge (10.7/15 vs 8.8/15 correct answer; p<0.03).
CONCLUSIONS CONCLUSIONS
The TPE for AHSCT patients improved knowledge, reduced anxiety and depression, which consequently increasing QoL. Therefore, we recommend our approach to further engage patients in the treatment plan, which should specifically take place prior to AHSCT initiation.

Identifiants

pubmed: 32952978
doi: 10.4084/MJHID.2020.067
pii: mjhid-12-1-e2020067
pmc: PMC7485479
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e2020067

Déclaration de conflit d'intérêts

Competing interests: The authors declare no conflict of Interest.

Références

BMC Med. 2009 Dec 16;7:79
pubmed: 20015347
J Cancer Educ. 2011 Mar;26(1):12-21
pubmed: 21161465
Breast Cancer Res Treat. 2000 May;61(2):131-7
pubmed: 10942098
Rev Lat Am Enfermagem. 2018 Oct 25;26:e3065
pubmed: 30379249
Cancer. 2000 Jun 15;88(12):2817-23
pubmed: 10870066
Cochrane Database Syst Rev. 2016 Nov 24;11:CD008144
pubmed: 27883365
Patient Educ Couns. 2001 Jul;44(1):65-9
pubmed: 11390160
J Cancer Educ. 1996 Spring;11(1):32-8
pubmed: 8777153
Cancer Nurs. 2010 Mar-Apr;33(2):E24-32
pubmed: 20142739
Psychosom Med. 1984 May-Jun;46(3):199-212
pubmed: 6739680
Am J Nurs. 2015 Nov;115(11):22-34; quiz 35
pubmed: 26473441
In Vivo. 2020 Mar-Apr;34(2):771-777
pubmed: 32111783
Support Care Cancer. 2019 Sep;27(9):3537-3544
pubmed: 30685792
J Clin Oncol. 2003 Dec 1;21(23 Suppl):253s-265s
pubmed: 14645405
J Clin Oncol. 2013 Oct 10;31(29):3616-7
pubmed: 24002494
Bone Marrow Transplant. 2012 Apr;47(4):473-82
pubmed: 21602898
BMC Pulm Med. 2014 Dec 16;14:204
pubmed: 25515007
Bone Marrow Transplant. 2016 Apr;51(4):553-9
pubmed: 26752142
Jpn J Clin Oncol. 2001 May;31(5):188-94
pubmed: 11450992
Arch Gen Psychiatry. 1993 Sep;50(9):681-9
pubmed: 8357293
Br J Haematol. 2010 Feb;148(3):373-85
pubmed: 19919651
Bone Marrow Transplant. 2012 Aug;47(8):1131-3
pubmed: 22139070
Prof Inferm. 2019 Apr-Jun;72(2):120-128
pubmed: 31550428

Auteurs

Marco Cioce (M)

UOC Ematologia e Trapianto di Cellule Staminali Emopoietiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

Franziska Michaela Lohmeyer (FM)

Direzione scientifica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

Rossana Moroni (R)

Direzione scientifica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

Marinella Magini (M)

UOC Nutrizione clinica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

Alessandra Giraldi (A)

UOC Nutrizione clinica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

Paola Garau (P)

UOC Ematologia e Trapianto di Cellule Staminali Emopoietiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

Maria Carola Gifuni (MC)

UOC Ematologia e Trapianto di Cellule Staminali Emopoietiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

Vezio Savoia (V)

Servizio di Psico-Oncologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

Danilo Celli (D)

Facoltà di Medicina e Psicologia, Università "La Sapienza", Roma, Italy.

Stefano Botti (S)

UOC Ematologia, Azienda USL-IRCCS di Reggio Emilia, Italy.

Gianpaolo Gargiulo (G)

UOC Ematologia, Università "Federico II", Napoli, Italy.

Francesca Bonifazi (F)

Istituto di Ematologia "Seràgnoli", Policlinico Universitario S.Orsola-Malpighi, Bologna, Italy.

Fabio Ciceri (F)

IRCCS Ospedale San Raffaele, Milano, Italy.

Ivana Serra (I)

Direzione SITRA, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

Maurizio Zega (M)

Direzione SITRA, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

Simona Sica (S)

Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy.

Andrea Bacigalupo (A)

Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy.

Valerio De Stefano (V)

Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy.

Umberto Moscato (U)

Istituto di Sanità pubblica, Università Cattolica del Sacro Cuore, Roma, Italy.

Classifications MeSH